representative work

Bio Pharma Acquired by HEALWELL for Consideration of up to $15 Million


On July 1, 2024, Think Research Corporation, a company focused on transforming healthcare through digital health software solutions, closed the sale of its previously announced transaction with HEALWELL AI Inc., a TSX-listed healthcare technology company focused on AI and data science for preventative care, pursuant to which Think Research agreed to sell all of the issued and outstanding shares of its wholly-owned subsidiary, Bio Pharma Services Inc., one of Canada’s largest full-service “contract research organizations” focused on bioequivalence and early-stage clinical trials, to HEALWELL.

As consideration for the transaction, Think Research received consideration valued at up to $15 million, consisting of, among other things, a combination of cash, Class A Subordinate Voting Shares in the capital of HEALWELL and an earn-out.

Cassels acted for Think Research.